FDAnews
www.fdanews.com/articles/181498-synaptive-medical-wins-ce-mark-and-approval-in-australia-for-brightmatter-plan

Synaptive Medical Wins CE Mark and Approval in Australia for BrightMatter Plan

April 25, 2017

Toronto–based Synaptive Medical has received a CE Mark in Europe as well as regulatory approval in Australia for its BrightMatter Plan neurosurgical planning system.

The device generates a 3D whole brain image of the white matter in the brain, enabling surgeons to create preoperative plans that allow for less disruptive, more accurate surgery.

BrightMatter Plan is also FDA and Health Canada approved. — Cynthia Jessup

View today's stories